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1. PUBLIC HEALTH STATEMENT
 
1.1 WHAT IS N-NITROSODI-n-PROPYLAMINE?
 
N-Nitrosodi-n-propylamine is a yellow liquid at room temperature that
 
does not disssolve in water and evaporates slowly. It is a man-made
 
chemical made in small amounts for use in research. There is no evidence
 
that N-nitrosodi-n-propylamine exists naturally in soil, air, food, or
 
water. Small amounts of N-nitrosodi-n-propylamine are produced as a side
 
reaction during some manufacturing processes, as a contaminant in some
 
commonly available weed killers (dinitroaniline-based), and during the
 
manufacture of some rubber products. When exposed to sunlight, N-nitrosodi-n­
propylamine usually does not last for more than a day. Without sunlight
 
(e.g, in water deeper than sunlight reaches or in subsurface soil)
 
N-nitrosodi-n-propylamine breaks down slowly. It takes between 14 and 80
 
days for one-half of any certain amount of N-nitrosodi-n-propylamine to
 
break down when it is released to the subsurface soil. More information can
 
be found in Chapters 3, 4, and 5.
 
1.2 HOW MIGHT I BE EXPOSED TO N-NITROSODI-n-PROPYLAMINE?
 
Persons may be exposed to N-nitrosodi-n-propylamine by eating foods
 
treated with nitrite preservatives (e.g., cheeses, cured meats) and drinking
 
certain alcoholic beverages. N-Nitrosodi-n-propylamine forms in the stomach
 
during digestion of nitrite-treated foods and foods that contain certain
 
amines, particularly di-n-propylamine. Amines occur in some medicines and
 
in a variety of foods. Levels of N-nitrosodi-n-propylamine found in food
 
and alcoholic beverages range between 0.03 parts per billion (ppb) in fried,
 
salt-preserved fish to 30 ppb in cheese. The general population may be
 
exposed to N-nitrosodi-n-propylamine in cigarette smoke. Workers making
 
molded rubber products have been exposed to levels of N-nitrosodi-n-propylamine
 
in workroom air that were measured in parts of compound per
 
trillion parts (ppt) of air. Workers applying contaminated weed killers may
 
also be exposed to extremely low (ppt) levels of N-nitrosodi-n-propylamine.
 
At this time, N-nitrosodi-n-propylamine has been found in at least 1 of
 
1177 hazardous waste sites on the National Priorities List (NPL) in the
 
United States. Workers and the general population at these sites could
 
possibly be exposed to this compound by skin contact, breathing, and eating
 
contaminated items. For more information, refer to Chapter 5.
 
1.3 HOW CAN N-NITROSODI-n-PROPYINE ENTER AND LEAVE MY BODY?
 
N-Nitrosodi-n-propylamine can enter the body when a person breathes
 
air that contains N-nitrosodi-n-propylamine, or eats food or drinks water
 
contaminated with N-nitrosodi-n-propylamine. N-nitrosodi-n-propylamine is
 
not likely to get into your body unless you eat certain foods, drink
 
alcoholic beverages, or are exposed to it at a waste disposal site by
 
breathing N-nitrosodi-n-propylamine vapors. It is likely that N-nitrosodi-n­
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pesticides, or soil that contains it. Experiments with animals suggest that
 
if N-nitrosodi-n-propylamine enters the body, it will be broken down into
 
other compounds and will leave the body in the urine. More information on
 




1.4 HOW CAN N-NITROSODI-n-PROPYLAMINE AFFECT MY HEALTH?
 
The effects of short- or long-term exposures to N-nitrosodi-n-propylamine
 
on human health have not been studied. Little is known about
 
the health effects of short exposures to N-nitrosodi-n-propylamine in
 
experimental animals except that eating or drinking certain amounts of this
 
chemical can cause liver disease and death. Long-term exposure of
 
experimental animals to N-nitrosodi-n-propylamine in food or drinking water
 
causes cancer of the liver, esophagus, and nasal cavities. Although human
 
studies are not available, the animal evidence indicates that it is
 
reasonable to expect that exposure to N-nitrosodi-n-propylamine by eating
 
or drinking could cause liver disease and cancer in humans. It is not known
 
.whether other effects, such as birth defects, occur in animals or could
 
occur in humans exposed to N-nitrosodi-n-propylamine by eating or drinking.
 
It is also not known whether exposure to N-nitrosodi-n-propylamine by
 
breathing contaminated air or contact with the skin can affect the health of
 
animals or humans. Liver disease and cancer due to exposure to N-nitrosodi-n­
propylamine by breathing or skin contact are, however, a possibility and a
 
health concern. More information on the health effects of N-nitrosodi-n­
propylamine is given in Chapter 2.
 
1.5	 IS THERE A MEDICAL TEST TO DETERMINE WHETHER I HAVE BEEN EXPOSED TO N­
NITROSODI-n-PROPYLAMINE?
 
The presence of N-nitrosodi-n-propylamine in blood and urine can be
 
measured by chemical analysis, but this analysis is not usually available
 
at your doctor's office and has not been used to test for human exposure or
 
to predict possible health effects. These considerations are discussed in
 
more detail in Chapter 2.
 
1.6 WHAT LEVELS OF EXPOSURE HAVE RESULTED IN HARMFUL HEALTH EFFECTS?
 
Tables l-1 through 1-4 show the relationship between exposure to
 
N-nitrosodi-n-propylamine and known health effects. As indicated in Tables
 
l-1 and 1-2, nothing is known about the health effects on humans or animals
 
of breathing N-nitrosodi-n-propylamine. Also, nothing is known-about the
 
health effects in humans of eating food or drinking water containing
 
N-nitrosodi-n-propylamine (Table l-3). A Minimal Risk Level (MRL) is also
 
included in Table l-3. This MRL was derived from animal data for short-term
 
exposure as described in Chapter 2 and in Table 2-1. The MRL provides a
 
basis for comparison with levels that people might encounter in drinking
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below the MRL, it is not expected that harmful (noncancer) health effects
 
will occur. Because this level is based on information that is currently
 
available, some uncertainty is always associated with it. Also, because the
 
method for deriving MRLs does not use any information about cancer, an MRL
 
does not imply anything about the presence, absence, or level of risk of
 
cancer. The levels of N-nitrosodi-n-propylamine in food and drinking water
 
linked with known health effects in animals are given in Table l-4. It is
 
not known whether skin contact with N-nitrosodi-n-propylamine can affect the
 
health of humans or animals. More information on levels of exposure linked
 
with adverse health effects can be found in Chapter 2.
 




The EPA controls the release of N-nitrosodi-n-propylamine. It is
 
proposed that releases or spills of 10 pounds or more of N-nitrosodi-n-propylamine
 
must be reported to the National Response Center.
 
1.8 	 WHERE CAN I GET MORE INFORMATION?
 
If you have more questions or concerns, please contact your State
 
Health or Environmental Department or:
 
















This chapter contains descriptions and evaluations of studies and
 
interpretation of data on the health effects associated with exposure to
 
N-nitrosodi-n-propylamine. Its purpose is to present levels of significant
 
exposure for N-nitrosodi-n-propylamine based on toxicological studies,
 
epidemiological investigations, and environmental exposure data. This
 
information is presented to provide public health officials, physicians,
 
toxicologists, and other interested individuals and groups with (1) an
 
overall perspective of the toxicology of N-nitrosodi-n-propylamine and (2) a
 




2.2 DISCUSSION OF HEALTH EFFECTS BY ROUTE OF FXPOSURE
 
To help public health professionals address the needs of persons
 
living or working near hazardous waste sites, the data in this section are
 
organized first by route of exposure -- inhalation, oral, and dermal -- and
 
then by health effect -- death, systemic, immunological, neurological,
 
developmental, reproductive, genotoxic, and carcinogenic effects. These
 




Levels of significant exposure for each exposure route and duration
 
(for which data exist) are presented in tables and illustrated in figures.
 
The points in the figures showing no-observed-adverse-effect levels (NOAELS)
 
or lowest-observed-adverse-effect levels (LOAELs) reflect the actual doses
 
(levels of exposure) used in the studies. LOAELs have been classified into
 
"less serious" or "serious" effects. These distinctions are intended to
 
help the users of the document identify the levels of exposure at which
 
adverse health effects start to appear, determine whether or not the
 
intensity of the effects varies with dose and/or duration, and place into
 
perspective the possible significance of these effects to human health.
 
The significance of the exposure levels shown on the tables and graphs
 
may differ depending on the user's perspective. For example, physicians
 
concerned with the interpretation of clinical findings in exposed persons or
 
with the identification of persons with the potential to develop such
 
disease may be interested in levels of exposure associated with "serious"
 
effects. Public health officials and project managers concerned with
 
response actions at Superfund sites may want information on levels of
 
exposure associated with more subtle effects in humans or animals (LOAEL) or
 
exposure levels below which no adverse effects (NOAEL) have been observed.
 
Estimates of levels posing minimal risk to humans (minimal risk levels,
 






For certain chemicals, levels of exposure associated with carcinogenic
 
effects may be indicated in the figures. These levels reflect the actual
 
doses associated with the tumor incidences reported in the studies cited.
 
Because cancer effects could occur at lower exposure levels, the figures
 
also show estimated excess risks, ranging from a risk of one in 10,000 to
 
one in 10,000,000 (10-4 to 10-7), as developed by EPA.
 
Estimates of exposure levels posing minimal risk to humans (MRLs) have
 
been made, where data were believed reliable, for the most sensitive
 
noncancer end point for each exposure duration. MRLs include adjustments to
 
reflect human variability and, where appropriate, the uncertainty of
 
extrapolating from laboratory animal data to humans. Although methods have
 
been established to derive these levels (Barnes et al. 1987; EPA 1980a),
 




No studies were located regarding the following effects in humans or
 
animals following inhalation exposure to N-nitrosodi-n-propylamine:
 
2.2.1.1 Death 
2.2.1.2 Systemic Effects 
2.2.1.3 Neurological Effects 
2.2.1.4 Immunological Effects 
2.2.1.5 Developmental Effects 
2.2.1.6 Reproductive Effects 
2.2.1.7 Genotoxic Effects 
2.2.1.8 Cancer 
2.2.2 Oral Exposure 
2.2.2.1 Death 




Druckrey et al. (1967) determined a single dose gavage LD50 of 480
 
mg/kg for N-nitrosodi-n-propylamine in rats. The value was determined using
 
an unspecified graphic technique but specific mortality data were not
 
reported. Deaths occurred after 3-7 days and appear to have been due
 
primarily to hepatotoxicity. Other acute oral lethality data were not
 







Table 2-1 and Figure 2-l. No short-term studies of N-nitrosodi-n-propylamine
 
administered in drinking water were located; therefore, the dose level of
 
480 mg/kg, which was administered by gavage in water (Druckrey et al. 1967),
 
was converted to an equivalent concentration of 3400 ppm in water for
 
presentation in Table l-4.
 
Decreased longevity occurred in rats that were treated with
 
N-nitrosodi-n-propylamine at doses of 6.3 mg/kg/day (females) or 12.6
 
mg/kg/day (males) by gavage for 2 days/week for 30 weeks (Lijinsky and
 
Reuber 1983), or 5.1 mg/kg/day (males) via drinking water for 5 days/week
 
for 30 weeks (Lijinsky and Taylor 1978, 1979). Mortality in the Lijinsky and
 
Reuber (1983) study was 92-100% after 40-60 weeks compared to 5-10% after
 
100 weeks in controls; comparable data were reported by Lijinsky and Taylor
 
(1978, 1979) for the treated rats but a control group was not used. The
 
mortality in these studies was due to tumor development (see Section
 
2.2.2.8, Oral exposure, Cancer). The 5.1, 6.3 and 12.6 mg/kg/day doses are
 
serious LOAEL values for lethality in rats due to intermediate duration oral
 
exposure and are recorded in Table 2-l and plotted in Figure 2-l. No studies
 






No studies were located regarding systemic effects in humans following
 
oral exposure to N-nitrosodi-n-propylamine.
 
Hepatic Effects. Pathologic examinations of rats that received single
 
lethal doses of various nitrosamines, including N-nitrosodi-n-propylamine,
 
showed centrilobular necrosis and fatty degeneration of the liver (Druckrey
 
et al. 1967). Specific doses of N-nitrosodi-n-propylamine that produced
 
these effects were not reported, but the LD50 was determined to be 480
 
mg/kg; this dose is indicated in Table 2-l and Figure 2-l as a serious LOAEL
 
for hepatic effects in rats due to acute oral exposure. No short-term
 
studies of N-nitrosodi-n-propylamine administered in drinking water were
 
located; therefore, the dose level of 480 mg/kg, which was administered by
 
gavage in water (Druckrey et al. 1967), was converted to an equivalent
 
concentration of 3400 ppm in water for presentation in Table l-4.
 
Nishie et al. (1972) determined pentobarbital sleeping time (PST) in
 
mice that were treated by gavage with single doses or with four consecutive
 
daily doses of various nitrosamines, including N-nitrosodi-n-propylamine.
 
Doses of N-nitrosodi-n-propylamine were 160 mg/kg/day in the single dose
 
study and 40 mg/kg/day in the four-day study. N-nitrosodi-n-propylamine
 
treatment resulted in significantly prolonged PST in both studies. Liver
 
histology was evaluated in the four-day study, but results of the histologic
 
examinations were not reported specifically for any of the nitrosamines.
 
Hepatic histological alterations attributed to unspecified nitrosamines
 
included hepatocyte swelling and necrosis in the centrilobular areas; due to
 









n-propylamine was among the nitrosamines that produced these effects.
 
However, considering the aforementioned findings for nitrosamines in general
 
as well as evidence for hepatotoxicity of N-nitrosodi-n-propylamine and
 
other nitrosamines from other studies, the increase in PST provides an
 
indirect indication of adverse liver effects. Therefore, since N-nitrosodi-n­
propylamine markedly increased PST in the four-day study, 40 mg/kg/day can
 
be regarded as a LOAEL for less serious hepatic effects due to acute oral
 
exposure (Table 2-l and Figure 2-l). No short-term studies of N-nitrosodi-n­
propylamine administered in food were located; therefore, the dose level of
 
40 mg/kg/day, which was administered by gavage in olive oil (Nishie et al.
 
1972), was converted to an equivalent concentration of 308 ppm in food for
 
presentation in Table l-4.
 
Liver histology and activities of liver-associated serum enzymes (SGOT,
 
alkaline phosphatase, lactate dehydrogenase, gamma-glutamyl-transferase)
 
were unaltered in mice exposed to 9.5 mg/kg/day via drinking water for one
 
week (Tyndall et al. 1978). This dose represents a NOAEL for hepatic effects
 
due to acute duration exposure (Table 2-l and Figure 2-l). Because this
 
NOAEL is lower than the 40 mg/kg/day LOAEL for hepatic effects (Nishie et
 
al. 1972), it can be used as the basis for an acute MRL (Figure 2-l). Based
 
on this value, an acute oral MRL of 0.095 mg/kg/day was calculated, as
 
described in the footnote in Table 2-l. This MRL has been converted to an
 




Other Effects. Plasma esterase profiles were examined in mice exposed
 
to various carcinogenic, weakly carcinogenic and noncarcinogenic chemicals
 
in the drinking water for one week (Tyndall et al. 1978). N-nitrosodi-n­
propylamine, administered at a dose 9.5 mg/kg/day, produced esterase
 
alterations that were similar to those produced by other N-nitrosodialkylamines.
 
The alterations were not accompanied by weight loss, altered liver-associated
 
serum enzymes or histologic effects. This study was conducted to determine whether
 
altered esterase patterns in plasma would provide a more sensitive indicator of
 
exposure to a carcinogenic chemical than standard clinical chemistry tests. It was
 
concluded that it is not known if the altered esterase profiles that were observed
 
for N-nitrosodi-n-propylamine and the other carcinogens are related to
 
carcinogenicity, toxicity or metabolism. Since the biological significance of the
 
altered esterase profiles is unknown, it cannot be determined if 9.5 mg/kg/day
 




No studies were located regarding the following effects in humans or
 








2. HEALTH EFFECTS 
2.2.2.5 Developmental Effects 
2.2.2.6 Reproductive Effects 
2.2.2.7 Genotoxic Effects 
Single doses of N-nitrosodi-n-propylamine, administered by gavage,
 
produced fragmentation of liver DNA in rats (Brambilla et al. 1981, 1987a).
 




No studies were located regarding carcinogenic effects in humans
 
following oral exposure to N-nitrosodi-n-propylamine.
 
The carcinogenicity of N-nitrosodi-n-propylamine has been demonstrated
 
unequivocally in oral studies. High incidences of liver carcinomas, nasal
 
cavity carcinomas, esophageal carcinomas and papillomas, forestomach tumors
 
or tongue tumors occurred in rats that were exposed to N-nitrosodi­
npropylamine by gavage at doses of 6.3 or 12.6 mg/kg/day for 2 days/week for
 
30 weeks (Lijinsky and Reuber 1983), via drinking water at a dose of 2.6
 
mg/kg/day for 5 days/week for 30 weeks (Lijinsky and Reuber 1981), via
 
drinking water at a dose of 5.1 mg/kg/day for 5 days/week for 30 weeks
 
(Lijinsky and Reuber 1981; Lijinsky and Taylor 1978, 1979), and via diet
 
daily at reported doses of 4-30 mg/kg/day for life (survival duration not
 
specified) (Druckrey et al. 1967). Tumor incidences in the liver, nasal
 
cavity, esophagus and forestomach were generally in the range of 60-l00%,
 
and tongue tumor incidences ranged from 30-40%. The Lijinsky and Reuber
 
(1983) study was the only study that used control groups; no tumors
 
occurred in the control rats at any of the sites in which tumors developed
 
in the treated rats. The lack of controls in the other studies is not
 
considered to be a serious deficiency due to the high tumor incidences. As
 
indicated in Section 2.2.2.1 (Oral exposure, Death), tumor development in
 
all of the rat studies was life-shortening.
 
The lowest drinking water and gavage doses of N-nitrosodi-n-propylamine
 
that were carcinogenic to rats are 2.6 mg/kg/day (Lijinsky and
 
Reuber 1981) and 6.3 mg/kg/day (Lijinsky and Reuber 1983), respectively;
 
these are intermediate duration effect levels for carcinogenicity (cancer
 
effects levels, CELs) because exposure durations were 30 weeks (Table 2-l
 
and Figure 2-l). The lowest dose tested in the study of Druckrey et al.
 
(1967) (4 mg/kg/day) is also presented in Table 2-l and Figure 2-l in the
 
intermediate duration category as this study is used as the basis for a
 
carcinogenic potency factor for N-nitrosodi-n-propylamine (EPA 1988). The 4
 
mg/kg/day dose from the Druckrey et al. (1967) study is considered to be the
 
lowest CEL due to intermediate duration exposure because (1) time to tumor
 
data suggest that survival was generally less than one year, and (2)
 






similar or lower doses. Although a carcinogenic potency factor is based on
 
this study, it should be recognized that the study is limited by small
 
numbers of treated rats, no controls and unreported specific tumor
 
incidences. Using hepatocellular carcinoma response data from this study,
 
EPA (1988) derived and verified an oral slope factor (BH) of 7.0
 
(mg/kg/day)-1 for N-nitrosodi-n-propylamine. Using this slope factor the
 
10-4
doses associated with upper bound lifetime cancer risk levels of to
 
10-7 are calculated to be 1.4 x 10-5 to 1.4 x 10-8 mg/kg/day, respectively.
 
The cancer risk levels are plotted in Figure 2-l in the chronic duration
 
category because they represent lifetime risks for humans.
 
In an oral carcinogenicity study conducted with mice, the animals
 
received an estimated N-nitrosodi-n-propylamine dose of 1 mg/kg by gavage,
 
twice a week for 50 weeks (Griciute et al. 1982). Incidences of forestomach
 
papillomas, forestomach carcinomas and pulmonary adenomas were significantly
 
higher than in mice that were similarly treated with 40% ethanol; a vehicle
 
(water) control was not used. The 1 mg/kg/day dose from the Griciute et al.
 






No studies were located regarding the following effects in humans or
 
animals following dermal exposure to N-nitrosodi-n-propylamine:
 
2.2.3.1 Death 
2.2.3.2 Systemic Effects 
2.2.3.3 Neurological Effects 
2.2.3.4 Immunological Effects 
2.2.3.5 Developmental Effects 
2.2.3.6 Reproductive Effects 
2.2.3.7 Genotoxic Effects 
2.2.3.8 Cancer 
2.3  RELEVANCE TO PUBLIC HEALTH 
Death. Information regarding death of humans following exposure to
 
N-nitrosodi-n-propylamine by any route was not found. Case reports indicate
 
that intentional oral and accidental inhalation exposures to unknown levels
 
of N-nitrosodimethylamine, however, have resulted in deaths in humans
 
(Barnes and Magee 1954, Cooper and Kimbrough 1980, Freund 1937, Fussgaenger
 






to hepatotoxicity. Limited data are available for acute lethality in
 
N-nitrosodi-n-propylamine-exposed animals. In the only acute study that used
 
a natural route of exposure, an oral LD50 value of 480 mg/kg was determined
 
for rats (Druckrey et al. 1967). Subcutaneous injection LD50 values have
 
been determined for N-nitrosodi-n-propylamine in various species; these are
 
consistent with the oral LD50 and include 487.2 mg/kg for rats (Reznik et
 
al. 1975), 689 mg/kg for mice (Dickhaus et al. 1977) and 600 mg/kg for
 
hamsters (Pour et al. 1973). Pathologic examinations revealed centrilobular
 
liver necrosis and hemorrhages in the lungs, stomach, kidneys and/or heart.
 
Oral administration of N-nitrosodi-n-propylamine at doses ranging from
 
5.1-12.6 mg/kg/day, on 2 or 5 days a week for 30 weeks, produced high
 
mortality in rats (Lijinsky and Reuber 1983; Lijinsky and Taylor 1978,
 
1979). Once-weekly subcutaneous injections of similar doses of N-nitrosodin­
propylamine to rats (<24.4 mg/kg) (Reznik et al. 1975), mice (>34.5 mg/kg)
 
(Dickhaus et al. 1977) and hamsters (>3.75 mg/kg) (Pour et al. 1973, Althoff
 
et al. 1973a,b) also were life-shortening (average survival times of 27-54
 
weeks) . Weekly intraperitoneal injection of 40 mg/kg N-nitrosodi-n-propylamine
 
produced deaths in monkeys after an average period of 28 months
 
(Adamson and Sieber 1979, 1983). Mortality in the above studies is dose-

related and due to tumor development.
 
The available lethality data indicate that deaths resulting from acute
 
exposure to N-nitrosodi-n-propylamine are due primarily to hepatotoxicity,
 
that deaths resulting from repeated exposure to N-nitrosodi-n-propylamine
 
are due to tumors occurring primarily in the liver, and that causes of death
 
and lethal doses are similar in different species. The causes of death
 
produced by N-nitrosodi-n-propylamine also are consistent with those
 
produced by other dialkylnitrosamines (Magee et al. 1976).
 
Systemic Effects. Information regarding systemic effects in humans
 
following exposure to N-nitrosodi-n-propylamine was not found. Very limited
 
information is available for systemic effects of N-nitrosodi-n-propylamine
 




As indicated in the previous subsection (see Death above), lethal
 
single oral or subcutaneous doses of N-nitrosodi-n-propylamine produced
 
hepatic necrosis and hemorrhagic lesions in the liver and other internal
 
tissues in rats and hamsters (Druckrey et al. 1967, Pour et al. 1973, Reznik
 
et al. 1975). Similar effects were reported by Nishie et al. (1972), who
 
observed that gavage doses of 40 mg/kg/day for 4 consecutive days produced
 
swelling of hepatocytes and possibly necrosis in the centrilobular area of
 
the liver in mice. Hepatotoxicity and hemorrhagic lesions in the liver and
 
other internal tissues are also the primary acute effects of other
 
dialkylnitrosamine compounds (Magee et al. 1976). Based on data for other
 
dialkylnitrosamines, it can be inferred that systemic effects of
 
intermediate or chronic duration exposure to N-nitrosodi-n-propylamine are
 






Although it is apparent that N-nitrosodi-n-propylamine produces
 
hepatotoxicity and hemorrhages in the lungs, stomach, kidney and heart at
 
acute lethal doses in animals, there is only limited information regarding
 
the threshold for these effects following acute exposure and documentation
 
of these effects following intermediate or chronic duration exposure is not
 
available. Although human data are not available, human fatalities due to
 
intentional oral and accidental inhalation exposures to unknown levels of
 
N-nitrosodimethylamine have been described in case reports in which
 
hemorrhagic, necrotic and cirrhotic alterations in the liver and diffuse
 
internal bleeding were observed (Barnes and Magee 1954; Cooper and Kimbrough
 
1980; Freund 1937; Fussgaenger and Ditschuneits 1980; Pedal et al. 1982).
 
The available information for N-nitrosodi-n-propylamine and related
 
nitrosamines therefore indicates that N-nitrosodi-n-propylamine is likely to
 
produce characteristic hepatic and/or hemorrhagic effects in humans exposed
 
orally or by inhalation. Systemic effects of N-nitrosodi-n-propylamine may
 
result from dermal exposure, since evidence indicates that dermal absorption
 




Developmental Effects. Limited information regarding developmental
 
effects of N-nitrosodi-n-propylamine in humans or in animals is available
 
from subcutaneous injection transplacental carcinogenesis studies with
 
hamsters (Althoff et al. 1977a; Althoff and Grandjean 1979). Injection of a
 
single dose of 100 mg N-nitrosodi-n-propylamine/kg on day 8, 10, 12, or 14
 
of gestation did not produce gross malformations in the offspring but the
 
scope of the examination was not specified. However, transplacental
 
carcinogenicity was observed in the offspring of dams treated with
 
N-nitrosodi-n-propylamine. There were no treatment-related effects on litter
 
size but postnatal mortality in the first four weeks was increased (Althoff
 
et al. 1977a). Transplacental transport of N-nitrosodi-n-propylamine by the
 
hamsters was demonstrated by detection of the chemical in the placenta,
 
fetus and amniotic fluid. No studies were located demonstrating that
 
N-nitrosodi-n-propylamine crosses the placenta in humans and it is not known
 
whether N-nitrosodi-n-propylamine can cause developmental effects in humans.
 
It is relevant to note, however, that limited evidence indicates that
 
N-nitrosodimethylamine is fetotoxic but not teratogenic. Also, it has been
 
estimated from studies with rodents that drugs with a molecular weight of
 
less than 1,000 can readily cross the placenta (Mirkin 1973); the molecular
 
weight of N-nitrosodi-n-propylamine is 130.2.
 
Genotoxic Effects. No studies were located regarding the genotoxicity
 
of N-nitrosodi-n-propylamine in humans by the inhalation, oral or dermal
 
routes. Fragmentation of DNA was observed, however, in human hepatocytes
 




Genotoxicity of N-nitrosodi-n-propylamine has been demonstrated
 







N-nitrosodi-n-propylamine was mutagenic in bacteria (Salmonella
 
Typhimurium, Escherichia coli) and mammalian cells (mouse lymphoma L5178Y,
 
Chinese hamster V79), caused DNA effects (fragmentation, unscheduled
 
synthesis, repair) in rat hepatocytes, and chromosome aberrations in Chinese
 
hamster cells. The in vitro assays generally required addition of an
 
exogenous metabolic activation system for expression of effects; this is
 
consistent with the apparent indirect carcinogenicity of N-nitrosodi­
npropylamine. Single doses of N-nitrosodi-n-propylamine produced DNA
 
fragmentation in rats treated orally and sister chromatid exchange and DNA
 
synthesis suppression in mice treated by intraperitoneal injection (Table 2­
3). In addition, intraperitoneal injection (133 mg/kg) of N-nitrosodi-npropylamine
 
to rats results in propylation of DNA and RNA, an event regarded
 
as critical in the initiation of carcinogenesis by this and related
 
alkylating agents (Park et al. 1980).
 
The weight of evidence indicates that N-nitrosodi-n-propylamine is
 
genotoxic in mammalian cells. The effect observed in the study with human
 
hepatocytes (DNA fragmentation) (Brambilla et al. 1987b) is consistent with
 
the results of other assays, particularly the in vitro and in vivo rat
 
hepatocyte DNA fragmentation assays (Table 2-2 and 2-3). Given the type and
 
weight of genotoxicity evidence, one can predict that N-nitrosodi-n­
propylamine poses a genotoxic threat to humans.
 
Cancer. Information regarding the carcinogenicity of N-nitrosodi­
npropylamine in humans was not located. In animals, carcinogenicity of
 
N-nitrosodi-n-propylamine has been demonstrated in several species in all
 
studies that have been conducted. In rats observed for life, daily or
 
partial weekly (2 days/week or 5 days/week) oral exposure produced tumors
 
primarily in the liver, nasal cavity and esophagus (Druckrey et al. 1967;
 
Lijinsky and Reuber 1981, 1983; Lijinsky and Taylor 1978, 1979). In mice,
 
increased incidences of forestomach tumors occurred as a result of twice
 
weekly orally treatment for 50 weeks (Griciute et al. 1982). Weekly
 
subcutaneous injections of N-nitrosodi-n-propylamine to rats (Althoff et al.
 
1973b, Reznik et al. 1975), mice (Dickhaus et al. 1977) and hamsters
 
(Althoff et al. 1973a, 1977b; Pour et al. 1973, 1974) for life produced
 
high incidences of tumors primarily in the nasal cavity and other parts of
 
the respiratory system, but also in the liver and esophagus. Subcutaneous
 
injection of single 100 mg/kg doses of N-nitrosodi-n-propylamine into
 
hamsters during gestation induced tumors; primarily in the respiratory and
 
digestive tracts, in the dams and offspring (Althoff et al. 1977a; Althoff
 
and Grandjean 1979). Weekly intraperitoneal injections of 40 mg N-nitrosodin­
propylamine produced death due to hepatocellular carcinomas in monkeys
 
after an average duration of 28 months (Adamson and Sieber 1979, 1983).
 
Overall, there is conclusive evidence that N-nitrosodi-n-propylamine is
 
carcinogenic in animals. The carcinogenicity of N-nitrosodi-n-propylamine
 
may be related to alkylation of DNA. It is important to recognize that
 
cancer was observed in the oral and injection studies after durations as
 







exposure by injection were sufficient to induce cancer. Based on the
 
evidence of carcinogenicity in animals, it is reasonable to anticipate that
 
N-nitrosodi-n-propylamine will be carcinogenic in humans.
 
2.4 	 LEVELS IN HUMAN TISSUES AND FLUIDS ASSOCIATED WITH HEALTH EFFECTS
 
There is no known association between levels of N-nitrosodi-npropylamine
 
or its metabolites in human tissues and fluids and health
 
effects of N-nitrosodi-n-propylamine. N-nitrosodi-n-propylamine was detected
 
in the liver of 1 of 4 deceased subjects (Cooper et al. 1987). As indicated
 








There is no known association between levels of N-nitrosodi-npropylamine
 
in the environment and levels of N-nitrosodi-n-propylamine or
 










No studies were located regarding absorption in humans or animals
 
following inhalation exposure to N-nitrosodi-n-propylamine.
 
However, structurally similar compounds, such as, N-nitrosodimethylamine and
 
N-nitrosodiethanolamine, are readily absorbed (70-90% of the dose) following
 
inhalation exposure in experimental animals (Klein and Schmezer 1984;
 
Preussmann et al. 1981). Absorption was inferred by monitoring urinary
 








Specific information regarding absorption in animals following oral
 
exposure to N-nitrosodi-n-propylamine was not located. Gastrointestinal
 
absorption of N-nitrosodi-n-propylamine by rodents is indicated by the
 
occurrence of metabolites in the urine following oral treatment (Section
 
2.3.1.3) and systemic effects in oral carcinogenicity and toxicity studies
 
(Section 2.2). Other nitrosamines are rapidly absorbed from the
 
gastrointestinal tract after oral exposure. Diaz Gomez et al. (1977) found
 







from the stomach and intestine of rats 15 minutes after administration. Also
 
in rats, Lijinsky et al. (1981) and Preussmann et al. (1978) estimated
 
absorption rates of 25% and 70% of the dose for N-nitrosodiethanolamine,
 




No studies were located regarding absorption in humans following dermal
 
exposure to N-nitrosodi-n-propylamine. However, absorption of N­
nitroso-di-n-propylamine through human skin in vivo (Edwards et al. 1979) and
 
in vitro (Bronaugh et al. 1979, 1981) has been demonstrated.
 
Diffusion of N-nitroso-di-n-propylamine through rat skin in vitro has
 
been demonstrated (Wishnok et al. 1982). Information regarding dermal
 
absorption of N-nitroso-di-n-propylamine by animals in vivo was not located
 
in the reviewed literature. Dermal absorption of N-nitrosodiethanolamine has
 
been determined in pigs (Marzulli et al. 1981), monkeys (Marzulli et al.
 
1981), and rats (Airoldi et al. 1984; Lijinsky et al. 1981). The degree of
 
absorption varied greatly (4-78%) depending on the site of the application
 
and the vehicle used. Based on the data for N-nitrosodi-n-propylamine and
 
N-nitrosodiethanolamine, it is likely that N-nitrosodi-n-propylamine will be
 




Route-specific distribution data for N-nitrosodi-n-propylamine in
 
humans were not located in the reviewed literature. Quantitative analyses of
 
six volatile nitrosamines in postmortem organs (brain, liver, kidneys,
 
pancreas) from four human subjects were conducted (Cooper et al. 1987).
 
N-nitrosodi-n-propylamine was detected only in the liver of one of the
 
subjects (female, age 84 years) at a concentration of 19.30 ng/50 g of
 
tissue. The ages of the other subjects (two males, one female) ranged from
 




Transplacental transport of N-nitrosodi-n-propylamine was shown in
 
pregnant hamsters (Althoff et al. 1977a, Althoff and Grandjean 1979). After
 
a single 100 mg/kg subcutaneous injection, N-nitrosodi-n-propylamine was
 
detected in the maternal blood, placenta, fetus, and amniotic fluid. The
 
concentration of the chemical in maternal blood reached a maximum at 45 and
 
90 minutes after the injection, whereas a single peak at 90 minutes was
 
observed in the fetus. Analysis for metabolites was not conducted, but 1.6%
 
of the unchanged compound was found in the placenta and 1.3% in the fetus at
 
day 14 of gestation. Detection of 06-methylguanine in human placental DNA by
 
immunoassay indicates that nitrosamines, as a group, can reach the placenta
 
in humans (Foiles et al. 1988).
 
Limited data are available regarding the distribution of related
 
nitrosamines. Daugherty and Klapp (1976) reported that after oral
 






detected in the homogenates of heart, forestomach, esophagus, liver and
 
lungs. Radioactivity was detected in all organs and tissues of rats after
 
oral doses of 14C-N-nitrosodiethanolamine (Lethco et al. 1982). After
 
intravenous injection of 14C-N-nitrosodi-n-butylamine to rats the highest
 
concentrations of radiolabel occurred in the nasal mucosa, liver and
 




No studies were located regarding metabolism in humans following
 
exposure to N-nitrosodi-n-propylamine. .
 
In vitro and in vivo studies with rodents have been conducted that
 
provide evidence that N-nitrosodi-n-propylamine can be metabolized via
 
oxidation at the alpha, beta and gamma carbon positions (Figure 2-2). Alpha
 
carbon oxidation (hydroxylation) is regarded as the primary pathway,
 
resulting in formation of propionaldehyde and 1-propanol and 2-propanol as
 
metabolites (Farrelly et al. 1984; Park and Archer 1978; Park et al. 1977).
 
1-Propanol and 2-propanol are formed via propyldiazohydroxide and a propyl
 
cation (carbonium ion). It is generally believed that the carbonium ions can
 
also react with nucleic acids to form propylated adducts, but Park et al.
 
(1980) have suggested that propylation takes place via a bimolecular
 
reaction. However, reaction of DNA with propylnitrosourea (a direct acting
 
equivalent of N-nitrosodi-n-propylamine) results in formation of n-propyl
 
and isopropyl DNA adducts, suggesting carbonium ions are involved.
 
Alkylation of nucleic acids and proteins by metabolites of nitrosamines has
 
been suggested as the mechanism responsible for the toxic and carcinogenic
 
properties of these substances.
 
Beta-carbon hydroxylation yields N-nitroso-2-hydroxy-propylpropylamine
 
which is excreted as the glucuronide or further oxidized to a small extent
 
to N-nitroso-2-oxopropylpropylamine (Bauman et al. 1985; Leung and Archer
 
1981; Park and Archer 1978; Suzuki and Okada 1981). Methylated hepatic
 
nucleic acids have been recovered from rats and hamsters treated with
 
N-nitrosodi-n-propylamine (Althoff et al. 1977b; Kruger 1971, 1973; Kruger
 
and Bertram 1973; Leung and Archer 1984). Putative methylating
 




Gamma-carbon hydroxylation yields N-nitroso-3-hydroxy-propylpropylamine
 
and its oxidation product, N-propyl-N-(2-carboxyethyl)nitrosamine (Baumann
 
et al. 1985; Blattmann and Preussman 1973, Suzuki and Okada 1981). Urinary
 
N-propyl-N-(2-carboxyethyl)nitrosamine amounted to approximately 5% of a 300
 




Documented and postulated metabolites of N-nitrosodi-n-propylamine have
 








propylpropylamine, N-nitroso-bis(2-oxo-n-propyl)amine and N-nitroso-bis(2­
acetoxy-n-propyl)amine. Main tumor sites of many of these metabolites
 
include those associated with N-nitrosodi-n-propylamine treatment (Section
 






No studies were located regarding excretion in humans or animals
 








Rats excreted metabolites but not unchanged N-nitrosodi-n-propylamine
 
in the urine following oral dosing with N-nitrosodi-n-propylamine (Blattmann
 
and Preussmann 1973, Suzuki and Okada 1981). The principal metabolite in the
 
Suzuki and Okada (1981) study, N-propyl-N-(2-carboxyethyl)nitrosamine,
 
amounted to approximately 5% of the administered dose. Additional
 
information regarding the extent or rate of excretion in either of the
 








Excretion of unchanged N-nitrosodiethanolamine in the urine of rats has
 
been reported in several studies after cutaneous application of
 




2.7  INTERACTIONS WITH OTHER CHEMICALS
 
Ethanol was found to enhance the carcinogenicity of N-nitrosodi­
npropylamine. Mice that were treated with estimated 1 mg/kg doses of
 
N-nitrosodi-n-propylamine dissolved in 40% ethanol by gavage, twice a week
 
for 50 weeks, developed higher incidences of tumors than mice that were
 
similarly treated with the same dose of compound given in water (Griciute et
 
al. 1982). The most pronounced tumor enhancement was in the forestomach (51%
 
carcinomas vs. 10% in N-nitrosodi-n-propylamine/water group), but increases
 







2.8 POPULATIONS THAT ARE UNUSUALLY SUSCEPTIBLE
 
No populations with unusual susceptibility to health effects of
 
N-nitrosodi-n-propylamine have been identified. However, heavy consumers of
 
alcoholic beverages might be considered to be a susceptible population based
 
on a single report in which ethanol was shown to potentiate the
 
carcinogenicity of N-nitrosodi-n-propylamine in mice (Griciute et al. 1982).
 
2.9 ADEQUACY OF THE DATABASE
 
Section 104 (i) (5) of CERCLA, directs the Administrator of ATSDR (in
 
consultation with the Administrator of EPA and agencies and programs of the
 
Public Health Service) to assess whether adequate information on the health
 
effects of N-nitrosodi-n-propylamine is available. Where adequate
 
information is not available, ATSDR, in cooperation with the National
 
Toxicology Program (NTP), is required to assure the initiation of a program
 
of research designed to determine these health effects (and techniques for
 
developing methods to determine such health effects). The following
 
discussion highlights the availability, or absence, of exposure and toxicity
 
information applicable to human health assessment. A statement of the
 
relevance of identified data needs is also included. In a separate effort,
 
ATSDR, in collaboration with NTP and EPA, will prioritize data needs across
 
chemicals that have been profiled.
 
2.9.1 Existing Information on Health Effects of N-Nitrosodi-n-propylamine
 
Information regarding health effects of N-nitrosodi-n-propylamine in
 
humans is not available. Health effects of N-nitrosodi-n-propylamine in
 
animals have been investigated only in oral exposure studies. As indicated
 
in Figure 2-3, animal oral data are available for lethality, acute systemic
 
effects, genotoxicity and cancer. These data indicate that the acute
 
toxicity of N-nitrosodi-n-propylamine is attributable to hepatic effects and
 




Single Dose Exposure. Information on lethality (LD50) and severe
 
systemic effects in rats are available from one single dose oral study.
 
Similar information is available from single dose subcutaneous injection
 
studies with rats, mice and hamsters. Another oral study reported a nonlethal
 
effect (increased pentobarbital sleeping time) but none of the other
 
studies reported non-lethal doses or attempted to identify dose-response
 
data for other subtle systemic effects. Additional single dose oral studies
 
would provide better information on thresholds for lethality and systemic
 
toxicity as well as interspecies differences. Inhalation and dermal studies
 
with N-nitrosodi-n-propylamine have not been conducted; single dose studies
 
involving exposure by these routes would provide information on lethality,
 







Repeated Dose Exposure. Oral studies provide limited information on
 
the threshold for hepatotoxicity in mice. Several intermediate duration oral
 
studies with rats, one limited oral study with mice and injection studies
 
with rats, mice, hamsters and monkeys provide survival data but
 
noinformation on effects other than cancer. Additional short-term repeated
 
dose oral studies (e.g., 14-28 day studies) in various species could provide
 
additional information on systemic effects, particularly dose-response
 
characterization of hepatic/hemorrhagic effects. Repeated dose inhalation
 




Chronic Exposure and Carcinogenicity. Chronic oral toxicity data for
 
N-nitrosodi-n-propylamine are not available because treated animals have
 
died of cancer within one year of treatment. Animals treated with doses
 
lower than those used in the intermediate duration studies may survive
 
chronic exposure and provide information on nonneoplastic effects. With the
 
exception of a single study with mice, species other than rat have not been
 
tested for carcinogenicity by the oral route.
 
Genotoxicity. The genotoxicity of N-nitrosodi-n-propylamine is
 
documented but only one in vivo study used an environmentally relevant route
 
of exposure (oral), and only two studies (in vitro) evaluated human cells.
 
Additional studies, particularly types providing information on the
 




Reproductive Toxicity. Information on the reproductive toxicity of
 
N-nitrosodi-n-propylamine is not available. Histological examinations of
 
reproductive organs of animals exposed in subchronic and chronic studies
 
would provide relevant data. Multigenerational or continuous breeding
 
studies would provide further information regarding reproductive effects of
 
N-nitrosodi-n-propylamine in animals, which may be related to possible
 
reproductive effects in humans.
 
Developmental Toxicity. Some data on developmental toxicity are
 
available from single-dose subcutaneous injection studies with hamsters.
 
Developmental effects of N-nitrosodi-n-propylamine have not been
 
investigated in animals exposed by natural routes. Developmental studies in
 
animals by natural routes of exposure would provide information on possible
 
developmentally toxic effects, including transplacental carcinogenicity,
 
that might be relevant to humans. These studies should include postnatal
 




Immunotoxicity. Histological examination of organs and tissues of the
 
immunological system from animals exposed in subchronic and chronic studies
 
would provide relevant information as immunotoxicity data for N-nitrosodi-n­
propylamine are not available. Specific immunotoxicity tests or a battery of
 







immunotoxic effects. Sensitization tests in animals might provide
 
information on whether there is likely to be an allergic response to
 
N-nitrosodi-n-propylamine. Although the low molecular weight of
 
N-nitrosodi-n-propylamine would probably preclude activity as an antigen by
 
itself, it is possible that a higher molecular weight moiety resulting from
 




Neurotoxicity. Information on the neurotoxicity of N-nitrosodi-n-propylamine
 
is not available. A battery of tests for neurotoxicity would
 
provide further information of neurotoxicity in animals, which then might be
 
related to possible neurotoxic effects in humans.
 
Epidemiological and Human Dosimetry Studies. Health effects of
 
N-nitrosodi-n-propylamine have not been described in humans. Effects in
 
treated animals, however, include hepatotoxicity and cancer. As discussed in
 
Chapter 5, the potential for environmental exposure to N-nitrosodi-n-propylamine
 
is very low, and segments of the general population with
 
potentially high or specific exposure to N-nitrosodi-n-propylamine have not
 
been identified. N-nitrosodi-n-propylamine has been detected in rubber
 
manufacturing facilities but concentrations are low and exposure is
 
complicated by the presence of other nitrosamines and additional chemicals.
 
If N-nitrosodi-n-propylamine or its metabolites in urine can be
 
correlated with exposure in humans, it may be possible to monitor humans for
 
exposure. If toxic effects of N-nitrosodi-n-propylamine are identified in
 
humans, it may then be possible to correlate urinary levels of N-nitrosodin­
propylamine or one its metabolites with systemic effects.
 
Biomarkers of Disease. No disease states in humans produced by
 
exposure to N-nitrosodi-n-propylamine are known. If epidemiological studies
 
are conducted that correlate exposure with diseases, it may be possible to
 
identify subtle changes, such as altered blood chemistry indices, associated
 
with a particular disease state.
 
Disease Registries. Diseases in humans produced by exposure to
 
N-nitrosodi-n-propylamine are not known. If epidemiological studies
 
identify particular diseases produced by N-nitrosodi-n-propylamine, it may
 
be possible to determine the number of people affected and the factors
 
associated with identifying the disease in certain populations, such as,
 
those with exposure to high levels near hazardous waste sites.
 
Bioavailability from Environmental Media. No studies were located
 
regarding the bioavailability of N-nitrosodi-n-propylamine from
 
environmental media. The lack of data concerning levels in human tissues
 
and fluids does not necessarily indicate a lack of bioavailability since the
 
monitoring literature reports that N-nitrosodi-n-propylamine is present in
 
some foods, water, beverages and workroom air. It is, therefore, important
 






environmental samples. An understanding of the bioavailability of
 
N-nitrosodi-n-propylamine from environmental media may be obtained by
 
studying the biological fluids of individuals exposed to N-nitrosodi-n-propylamine
 
in the workplace or through the ingestion of N-nitrosodi-n-propylamine- containing
 
foods and beverages such as cheeses, cured meats, and
 
whiskey. Limited information is available regarding absorption parameters of
 
N-nitrosodi-n-propylamine in experimental animals. However, one could
 
assume, based on data obtained with other nitrosamines, that N-nitrosodi-n­
propylamine would be readily absorbed from the gastrointestinal tract if
 
ingested from contaminated soil.
 
Food Chain Bioaccumulation. No studies were available concerning food
 
chain bioaccumulation of N-nitrosodi-n-propylamine from environmental media.
 
The monitoring literature indicates that N-nitrosodi-n-propylamine has been
 
detected in samples of cooked fish and meat; however, occurrence of
 
N-nitrosodi-n-propylamine in these samples was not the result of
 
bioaccumulation, but was the result of formation resulting from preservation
 
and/or cooking. Various studies have also shown that N-nitrosamines, such
 
as N-nitrosodi-n-propylamine, form in the gastrointestinal tract during
 
digestion of foods containing secondary amines. Estimation techniques have
 
been used to determine that N-nitrosodi-n-propylamine would not
 
bioaccumulate in lipids of fish (see Section 5.3.1, Transport and
 
Partitioning). Based on this limited amount of information it is speculated
 
that human exposure to N-nitrosodi-n-propylamine through diet is not the
 
result of food chain bioaccumulation. Monitoring for the accumulation of
 
N-nitrosodi-n-propylamine in organisms from several trophic levels could be
 
used to support this conclusion.
 
Absorption, Distribution, Metabolism, Excretion. The general
 
metabolic pathways of N-nitrosodi-n-propylamine in animals have been
 
identified, but the relative contribution of the pathways in vivo,
 
particularly following exposure by natural routes, is inadequately
 
characterized. The identity of the alkylating agent(s) associated with
 
carcinogenesis is unclear. Information is available regarding absorption and
 
distribution of N-nitrosodi-n-propylamine. Evidence from other nitrosamines
 
indicates that a number of factors (e.g., species, route of exposure, dosing
 
schedule) appear to determine the organ specificity and the severity of the
 
effects induced by these compounds. Therefore, to fully characterize the
 
pharmacokinetics of N-nitrosodi-n-propylamine, studies of absorption,
 
distribution, metabolism, and excretion in animals following exposure by all
 
three routes are needed.
 
Comparative Toxicokinetics. The toxic and carcinogenic effects of
 
N-nitrosodi-n-propylamine are attributable to activity of metabolites but
 
no data are available to determine if there are quantitative differences in
 
metabolism among species. Information from other nitrosamines suggests that
 
there are species-characteristic tumors induced by nitrosamines. This seems
 
to be the reflection of differences in metabolic activities (and also repair
 






exercised when extrapolating possible effects in humans. Although toxicity
 
and carcinogenicity of N-nitrosodi-n-propylamine has been demonstrated in
 
rodents and monkeys, the animal species that serves as the best model for
 













Data pertaining to the chemical identity of N-nitrosodi-n-propylamine
 
are listed in Table 3-1.
 
3.2 PHYSICAL AND CHEMICAL PROPERTIES
 
The physical and chemical properties of N-nitrosodi-n-propylamine are
 











N-Nitrosodi-n-propylamine is not produced for commercial use in the
 
United States (HSDB 1988). The public portion of the EPA TSCA Production
 
File indicates that The Ames Laboratories in Milford, CT prepared <1000
 
pounds during 1977, and that Eastman-Kodak in Rochester, NY prepared none
 
during 1977, although it had the capability to do so and had prepared small
 
research quantities in the past (EPA 1977). N-nitrosodi-n-propylamine may
 
be produced as an impurity in the pesticides trifluralin, isopropalin, and
 
oryzalin (Cohen et al. 1978, Wotherspoon and Hindle 1988). N-Nitrosodi­










N-Nitrosodi-n-propylamine is prepared in laboratory-scale quantities
 




Landfill disposal procedures should be confirmed by responsible
 
environmental engineers and regulatory officials (OHM-TADS 1988).
 
N-nitrosodi-n-propylamine may be destroyed by high temperature incineration
 
in an incinerator equipped with an NOx scrubber (OHM-TADS 1988). Chemical
 
treatment methods may also be used to destroy N-nitrosodi-n-propylamine.
 
These methods involve (a) denitrosation by reaction with 3% hydrobromic acid
 
in glacial acetic acid, (b) oxidation by reaction with potassium
 
permanganate-sulfuric acid, or (c) extraction of the nitrosamine from the
 
waste using dichloromethane and subsequent reaction with triethyloxonium
 
tetrafluoroborate (TOEF) (Castegnaro et al. 1982).
 
4.5 ADEQUACY OF THE DATA BASE
 
Section 104 (i) (5) of CERCLA, directs the Administrator of ATSDR (in
 
consultation with the Administrator of EPA and agencies and programs of the
 
Public Health Service) to assess whether adequate information on the health
 
effects of N-nitrosodi-n-propylamine is available. Where adequate
 
information is not available, ATSDR, in cooperation with the National
 
Toxicology Program (NTP), is required to assure the initiation of a program
 
of research designed to determine these health effects (and techniques for
 
developing methods to determine such health effects). The following
 
discussion highlights the availability, or absence, of exposure and toxicity
 




4. PRODUCTION, IMPORT, USE, AND DISPOSAL
 
relevance of identified data needs is also included. In a separate effort,
 
ATSDR, in collaboration with NTP and EPA, will prioritize data needs across
 




Production, Use, Release, and Disposal. Uses, methods of synthesis,
 
and methods of disposal are described in the literature and there does not
 
appear to be a need for further information in these topics. Lack of
 
information pertaining to the import of this compound is to be expected
 
since this compound has no commercial significance and it is doubtful that
 
research quantities would be imported rather than prepared by laboratories
 
in the United States. Data regarding the amount of N-nitrosodi-npropylamine
 
released to air, water, and soil are needed in order to
 
establish potential sources of exposure and levels of exposure from
 
environmental media. In particular, releases from hazardous waste landfills
 
and industries in which this compound is inadvertently formed should be
 
established in order to determine whether people living in the vicinity of
 
these sites are exposed to elevated levels of this compound. According to
 
the Emergency Planning and Community Right to Know Act of 1986 (EPCRTKA),
 
(§313), (Pub. L. 99-499, Title III, §313), industries are required to submit
 
release information to the EPA. The Toxic Release Inventory (TRI), which
 
contains release information for 1987, became available in May of 1989.
 
This database will be updated yearly and should provide a more reliable
 
estimate of industrial production and emission.
 
Information on the production and environmental sources of di-npropylamine,
 
tri-n-propylamine and the N-oxide of tri-n-propylamine is
 
needed due to the possible presence of N-nitrosodi-n-propylamine as a
 
contaminant, and the possibility of inadvertent formation of N-nitrosodi­
npropylamine from reaction to these compounds with ubiquitous nitrate. There
 
is also a need to investigate whether N-nitrosodi-n-propylamine occurs in
 
waste sites where these precursor compounds are disposed due to occurrences
 








N-nitrosodi-n-propylamine is not an industrially or commercially
 
important chemical. It is produced in small, laboratory-scale quantities
 
for research purposes. It is also produced inadvertently during certain
 
manufacturing processes, occurring as an impurity in some dinitroaniline
 
pesticides and during manufacture of some extruded rubber products. Nitrosodi­
n-propylamine could also be present in certain secondary amines
 
(di-n-propylamine, tri-n-propylamine and the N-oxide of tri-n-propylamine)
 
as an impurity or due to inadvertent nitrosation of these amines in
 
industrial processes other than those mentioned above. Low levels of Nitrosodi-n­
propylamine may be released to the environment from contaminated
 
products, from industrial sites of inadvertent production or from disposal
 
of wastes containing this chemical. N-nitrosodi-n-propylamine could also be
 
released to the environment from waste disposal sites where the precursor
 
secondary amines have been discharged, but the potential for human exposure
 
from nitrosation of precursors at waste sites has not been evaluated.
 
N-Nitrosodi-n-propylamine is not expected to be a persistent
 
environmental contaminant. If released to the ambient atmosphere, it
 
should be degraded by direct photolysis and/or reaction with sunlight-

produced hydroxyl radicals (overall half-life typically on the order of
 
several hours). In water with significant exposure to sunlight,
 
N-nitrosodi-n-propylamine would be subject to rapid photolysis (half-life
 
about 2-3 hours). On soil surfaces, N-nitrosodi-n-propylamine would be
 
subject to rapid removal by photolysis and volatilization. The
 
volatilization half-life of N-nitrosodi-n-propylamine from soil surfaces
 
after spray application of a dinitroaniline herbicide was found to be
 
between 2 to 6 hours. In subsurface soil and in water beyond the
 
penetration of sunlight, N-nitrosodi-n-propylamine would be susceptible to
 
biodegradation under both aerobic and anaerobic conditions. In subsurface
 
soil, the half-life of N-nitrosodi-n-propylamine has been found to range
 
from 14 to 40 days under aerobic conditions and 47 to 80 days under
 
anaerobic conditions. At this time, N-nitrosodi-n-propylamine has been
 
found in at least 1 of 1177 hazardous waste sites on the National Priorities
 
List (NPL) in the United States (VIEW Database 1989).
 
Limited data are available concerning exposure of the general
 
population to N-nitrosodi-n-propylamine. It appears that exposure possibly
 
results from formation in the upper gastrointestinal tract during digestion
 
of certain foods or drugs that contain secondary amines, ingestion of some
 
foods containing N-nitrosodi-n-propylamine (e.g., certain cheeses, cured
 






5. POTENTIAL FOR HUMAN EXPOSURE
 




Occurrence of part per million levels of N-nitrosodi-n-propylamine in
 
various dinitroaniline herbicides may result in release of small amounts of
 
the nitrosamine into the atmosphere during and after application
 
(Cohen et al. 1978, Crosby 1979, Oliver 1981). Occurrence of N-nitrosodi-n­
propylamine in air in the production area of a rubber products plant where
 
common nitrosating agents (e.g., oxides of nitrogen) were used in
 
conjunction with rubber formulations containing secondary amine-based
 
compounds, suggests that plants using this type of production process are a
 




N-Nitrosamines may be formed inadvertently in situations in which
 
amines come in contact with nitrogen oxides, nitrous acid, nitrite salts,
 
nitro compounds or nitroso compounds (Fajen et al. 1980). This suggests
 
that under appropriate industrial conditions where di-n-propylamine is
 
present, N-nitrosodi-n-propylamine could be formed inadvertently and
 
released to the environment via effluent discharges. Limited monitoring
 
data which support this supposition indicate that N-nitrosodi-n-propylamine
 
has been released in wastewater from some textile plants and manufacturers
 
and/or users of amines. Small amounts of N-nitrosodi-n-propylamine may also
 
be released to surface waters either directly or indirectly (e.g., in
 
runoff) as a result of using dinitroaniline herbicides containing the
 




Small amounts of N-nitrosodi-n-propylamine may be released to soil
 
during the application of some dinitroaniline herbicides. For example, a
 
typical 1 kg per hectare application of trifluralin containing 1 part per
 
million (ppm) N-nitrosodi-n-propylamine would result in application of 0.01
 
ng nitrosamine per square centimeter (Oliver 1979). Federal regulations
 
require trifluralin formulations to contain <l ppm N-nitrosodi-n-propylamine
 
(EPA 1979). Data pertaining specifically to the formation of N-nitrosodi-n­
propylamine in soil were not found in the literature; however, formation of
 
N-nitrosodimethylamine (NDMA) in soil containing dimethylamine and nitrate
 
or nitrite suggests that a similar mechanism may exist for N-nitrosodi-n­




5.3.1  Transport and Partitioning
 
Organics having a vapor pressure of >10-4 mm Hg should exist almost
 




5. POTENTIAL FOR HUMAN EXPOSURE
 
estimated vapor pressure of N-nitrosodi-n-propylamine [0.086 mm Hg at 25°C
 
(see Table 3-2)] indicates that this compound should not partition from the
 
vapor phase to particulates in the atmosphere.
 
Using linear regression equations based on log Kow data [log Kow = 1.36
 
(see Table 3-2)], a bioconcentration factor of 6 and an adsorption
 
coefficient (Koc) of 129 have been estimated for N-nitrosodi-n-propylamine
 
(Bysshe 1982; Hansch and Leo 1985; Lyman 1982). These values indicate that
 
bioaccumulation in aquatic organisms and adsorption to suspended solids and
 
sediments in water would not be important fate processes. The low Henry's
 
Law constant for N-nitrosodi-n-propylamine [1.47x10-6 atm-m3/mol (see Table
 




If a herbicide containing N-nitrosodi-n-propylamine were applied to
 
warm, moist soil surfaces, most of the nitrosamine would be expected to
 
volatilize. The volatilization half-life from soil surfaces under field
 
conditions is estimated to be on the order of 2 to 6 hours (Berard and
 
Rainey 1979, Oliver 1979). If a herbicide containing N-nitrosodi-n­
propylamine were incorporated into soil (below the soil surface),
 
volatilization would be of minor importance (Oliver 1979). When
 
incorporated into soil, N-nitrosodi-n-propylamine is expected to be highly
 
mobile and it has the potential to leach into shallow groundwater supplies
 
(Saunders et al. 1979, Swann et al. 1983).
 




In the atmosphere, N-nitrosodi-n-propylamine vapor would be rapidly
 
degraded by direct photolysis and/or reaction with photochemically-generated
 
hydroxyl radicals. Crosby et al. (1980) determined a pseudo-first order
 
half-life of 5 to 7 hours for photolysis of N-nitrosodi-n-propylamine vapor
 
in air exposed to sunlight. Although experimental conditions did not
 
closely simulate environmental conditions (the concentration of N-nitrosodi-n­
propylamine was relatively high), results of this study did indicate that
 
N-nitrosodi-n-propylamine is susceptible to rapid photolysis. The half-life
 
for the reaction of N-nitrosodi-n-propylamine vapor with photochemically-

generated hydroxyl radicals has been estimated to be about 16 hours in
 
typical ambient air. This value is based on a reaction rate constant of
 






N-nitrosodi-n-propylamine is not expected to undergo abiotic
 
degradation under the conditions found in natural waters (Callahan et al.
 
1979, Oliver et al. 1979, Saunders and Mosier 1980). The dominant removal
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photolysis. A study of low levels (0.65 ppm) of N-nitrosodi-n-propylamine
 
in lake water resulted in a photolytic half-life of about 2.5 hours. The
 
major photoproduct was found to be n-propylamine, but the formation of
 
di-n-propylamine was also observed (Saunders and Mosier 1980). Beyond the
 
reach of sunlight it appears that N-nitrosodi-n-propylamine would be subject
 
to slow microbial degradation in aerobic waters (Tabak et al. 1981, Tate and
 
Alexander 1975). Insufficient data are available to predict the rate at
 




It appears that microbial degradation would be the dominant removal
 
process for the nitrosamine in subsurface soil under aerobic conditions.
 
Half-lives ranging from 14 to 40 days have been observed in aerobic
 
subsurface soil and from 47 to 80 days in anaerobic subsurface soil (Oliver
 
et al. 1979, Saunders et al. 1979, Tate and Alexander 1975). Initial losses
 
were due primarily to volatilization; however, biodegradation was the
 
dominant fate process. Available data on the degradation of the nitrosamine
 
in water and air, indicate that photolysis may be an important removal
 
process on soil surfaces.
 




There is no indication in the available literature that N-nitrosodi-n­
propylamine has been detected in ambient air in the United States. Air
 
samples collected above agricultural fields before, during, and after
 
application of the pesticide trifluralin contained no detectable levels of
 






No data were available regarding the monitoring and detection of
 
N-nitrosodi-n-propylamine in ambient surface water, groundwater, or drinking
 
water in the United States except at EPA National Priorities List (NPL)
 
hazardous waste sites. There were only a couple of monitoring studies
 
available pertaining to the occurrence N-nitrosodi-n-propylamine in treated
 
wastewater. In a survey of 32 U.S. textile plants, N-nitrosodi-n-propylamine
 
was detected at concentrations of 2-20 µg/L in 2 out of 32
 
samples of secondary effluent, while no detectable levels were found in
 
samples of raw wastewater from these same plants (Rawlings and Samfield
 
1979). This suggests that N-nitrosodi-n-propylamine was formed during the
 
treatment process. N-nitrosodi-n-propylamine has also been detected at a
 
maximum concentration of 1.2 µg/L in the final effluent from a German
 
chemical manufacturing plant involved in the manufacture and/or use of
 
amines (Hartmetz and Slemrova 1980). A survey of stormwater runoff samples
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that N-nitrosodi-n-propylamine is not a typical contaminant of stormwater
 
runoff (Cole et al. 1984). Water samples collected from agricultural fields
 
immediately following application of the pesticide trifluralin contained no
 
detectable levels of N-nitrosodi-n-propylamine (detection limit 0.01-0.02
 




Soil samples collected from agricultural fields immediately following
 
application of the pesticide trifluralin contained no detectable levels of
 
N-nitrosodi-n-propylamine (detection limit 0.2-l ng/g) (Ross et al. 1978,
 
West and Day 1979). It has been detected in at least 1 of 1177 NPL
 




A number of studies have focused on the monitoring of volatile
 
N-nitrosamines in various foodstuffs, including cheese, cured meats, cooked
 
fish, and alcoholic beverages; however, N-nitrosodi-n-propylamine has rarely
 
been detected (Alliston et al. 1972, Gavinelli et al. 1988, Goff and Fine
 
1979, Gross and Newberne 1977, Huang et al. 1981, Sen et al. 1987). The
 
nitrosamines appear to have formed in these foods as the result of the
 
reaction of secondary amines with the preservative sodium nitrite (Gray and
 
Dugan 1974). N-nitrosodi-n-propylamine has been monitored in food at the
 
following levels: salt-preserved fish (steamed), 0.050 µg/kg; salt-preserved
 
fish (fried), 0.030 µg/kg; salt-preserved fish (raw), not detected; cheese,
 
5-30 µg /kg; apple brandy, up to 3.6 µg/kg; cognac, rum and whiskey, up to
 
0.2 µg /kg (Cerutti et al. 1975, Gross and Newberne 1977, Huang et al. 1981,
 
IARC 1978). A study of cigarette smoke condensate from European cigarettes
 
showed that N-nitrosodi-n-propylamine was found at a level equivalent to 1
 
ng per cigarette in smoke condensate from 1 out of 11 types of cigarettes,
 
while condensate from 10 out of 11 cigarettes had levels below the detection
 
level of 0.5 ng per cigarette (McCormick et al. 1973). Although a number of
 
volatile N-nitrosamines have been identified in children's pacifiers and
 
baby-bottle nipples, N-nitrosodi-n-propylamine was not among them (Billedeau
 
et al. 1986, Gavinelli et al. 1988, Westin et al. 1987). Crops and plants
 
harvested from fields treated with the pesticides trifluralin, benefin, or
 
oryzalin contained no detectable levels of N-nitrosodi-n-propylamine
 
(detection limit 0.2 ng/g) (Ross et al. 1978, West and Day 1979).
 
In the mid-to-late 1970s, N-nitrosodi-n-propylamine was detected in the
 
herbicide trifluralin at levels as high as 154 mg/L, oryzalin at <l mg/L and
 
isopropalin at 39-87 mg/L (Cohen et al. 1978, Ross et al. 1977). Subsequent
 
to these findings, the production process for trifluralin was modified;
 
current levels of the nitrosamine in technical trifluralin are <l mg/L (EPA
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5.5 GENERAL POPULATION AND OCCUPATIONAL EXPOSURE
 
The potential for inhalation of N-nitrosodi-n-propylamine during
 
application and soil incorporation of trifluralin containing N-nitrosodi-n­
propylamine is extremely low; N-nitrosodi-n-propylamine levels in breathing
 
zone air of field workers should be on the order of several parts per
 
trillion or less (Day et al. 1982). During 1982, NIOSH carried out a
 
monitoring study at a plant where workers were involved in the production of
 
extruded rubber parts for automobile part interiors. Samples of personal
 
breathing-zone air were found to contain N-nitrosodi-n-propylamine at
 
concentrations ranging from 1.3 to 3.3 µg/m3 (241-611 ppt), with a mean
 
concentration of 2.3 µg/m3 (430 ppt). Airborne nitrosamine levels at this
 
plant were consistent with those found by NIOSH in other rubber industries
 
where the same type of extruding process was used. Volatile nitrosamines,
 
such as N-nitrosodi-n-propylamine, are emitted from heated rubber after
 
formation by the reaction of common nitrosating agents (e.g., oxides of
 
nitrogen) with secondary amine-based compounds frequently used in rubber
 
formulations (NIOSH 1982). N-nitrosodi-n-propylamine has been detected in
 
soil samples from at least one NPL site, and workers at NPL sites or other
 
hazardous waste sites could potentially be exposed to this compound by
 
inhalation and dermal contact. It is not certain whether direct skin
 




Based on limited data it appears that the general population may be
 
exposed to part per trillion levels of N-nitrosodi-n-propylamine in some
 
sodium nitrite-treated foods and certain alcoholic beverages. The general
 
population may be exposed to N-nitrosodi-n-propylamine as a result of its in
 
vivo formation during digestion in the upper gastrointestinal tract of
 
nitrite-containing and secondary amine-containing foods or drugs, especially
 
those containing di-n-propylamine (Groenen PJ et al. 1980, Magee et al.
 
1976; Sakai et al. 1984). One study pertaining to exposure to N-nitrosodi-n­
propylamine through inhalation of cigarette smoke suggests that there is a
 
possibility that low levels of this compound (on the order of 1 ng per
 
cigarette) may occur in cigarette smoke. There is no evidence of general
 
population exposure to N-nitrosodi-n-propylamine through ingestion of
 
contaminated drinking water or through dermal contact.
 
5.6 POPULATIONS WITH POTENTIALLY HIGH EXPOSURE
 
Data are not available for determining those segments of the general
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5.7 ADEQUACY OF THE DATA BASE
 
Section 104 (i) (5) of CERCLA, directs the Administrator of ATSDR (in
 
consultation with the Administrator of EPA and agencies and programs of the
 
Public Health Service) to assess whether adequate information on the health
 
effects of N-nitrosodi-n-propylamine is available. Where adequate
 
information is not available, ATSDR, in cooperation with the National
 
Toxicology Program (NTP), is required to assure the initiation of a program
 
of research designed to determine these health effects (and techniques for
 
developing methods to determine such health effects). The following
 
discussion highlights the availability, or absence, of exposure and toxicity
 
information applicable to human health assessment. A statement of the
 
relevance of identified data needs is also included. In a separate effort,
 
ATSDR, in collaboration with NTP and EPA, will prioritize data needs across
 




Physical and Chemical Properties. Physical and chemical properties are
 
essential for estimating the partitioning of a chemical in the environment.
 
Many physical and chemical properties are available for N-nitrosodi-n­
propylamine, but most do not have extensive experimental descriptions
 
accompanying the data so that an evaluation of the accuracy of the data is
 
difficult to make. Specifically, measured water solubility, vapor pressure,
 
Koc) and Henry's Law constant would be helpful in removing any doubt
 
concerning the accuracy of the data as well as provide information
 
concerning the uncertainty of these types of data. These data form the
 
basis for much of the input requirements for environmental models that
 




Environmental Fate. Data are available to establish, in general, the
 
environmental fate of N-nitrosodi-n-propylamine. It has been predicted that
 
in surface waters, beyond the reach of sunlight, N-nitrosodi-n-propylamine
 
would be subject to slow microbial degradation; however, data are needed to
 
determine its degradation rate in unlit surface water under aerobic or
 
anaerobic conditions. Natural water grab sample biodegradation studies and
 
soil metabolism studies carried out in the dark under both aerobic and
 
anaerobic conditions would be useful in establishing the persistence of
 
N-nitrosodi-n-propylamine in the environment. The dominant removal
 
mechanisms for N-nitrosodi-n-propylamine in air are expected to be
 
photolysis and reaction with photochemically generated hydroxyl radicals;
 
however, no data are available concerning the reaction pathway and the
 
products of these types of reactions. These types of data would be useful
 




Exposure Levels in Environmental Media. Data are needed to relate the
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levels of exposure resulting from its occurrence at these sites. Studies in
 
which air monitoring (ambient and personal air) in the vicinity of
 
contaminated sites and water sampling (groundwater and drinking water) at
 
locations where contamination from the site is most likely to occur would be
 
useful in establishing the extent of human exposure from contaminated sites.
 
N-Nitrosodi-n-propylamine has been detected on a few occasions in some
 
sodium nitrite-treated foods and alcoholic beverages and ingestion appears
 
to be a potential route of exposure; although, recent comprehensive data
 
regarding the occurrence of N-nitrosodi-n-propylamine in foods were not
 
available. A comprehensive survey of those food items in which N-nitrosodi­
n-propylamine may occur, including cheese, cured meats and fish, and
 
alcoholic beverages, would be useful in understanding the potential for
 
human exposure to N-nitrosodi-n-propylamine. Only one study was available
 
regarding the occurrence of N-nitrosodi-n-propylamine in cigarette smoke.
 
Results of this study do not provide strong conclusive evidence for
 
occurrence of measurable levels of N-nitrosodi-n-propylamine in cigarette
 




Exposure Levels in Humans. Limited data were available regarding human
 
exposure to N-nitrosodi-n-propylamine. It appears that the general
 
population may be exposed to N-nitrosodi-n-propylamine through various
 
foodstuffs, some alcoholic beverages, and possibly cigarette smoke; however,
 
data are needed to predict with certainty the frequency and level of
 
exposure. A few broad-based monitoring studies of air, water, and typical
 




Exposure Registries. An exposure registry currently is not available.
 
The development of a registry for exposures would provide a useful reference
 
tool in assessing exposure levels and frequency. In addition, a registry
 
would allow an assessment of the variations in exposure concentrations from,
 
for example, geography, season, regulatory actions, presence of hazardous
 
waste landfills, or manufacturing facilities. These assessment would, in
 
turn, provide a better understanding of the needs for some type of research
 
or data acquisition based on current exposure concentrations. Occupational
 
exposure to this compound is mainly through its inadvertent formation, so an
 




There is no indication that there are any studies currently in progress
 
which are related to the level of N-nitrosodi-n-propylamine in environmental
 
media, environmental fate of N-nitrosodi-n-propylamine, or general
 









Methods used for the analysis of N-nitrosodi-n-propylamine in
 
biological samples are shown in Table 6-l. The use of vacuum distillation
 
at low temperature (60-70°C) and trapping the distillate in dry ice/acetone
 
bath is the preferred method for the isolation of the compound from
 
biological matrices. Because of its selectivity and sensitivity, methods
 
using Thermal Energy Analyzer (TEA) detectors are selected for
 
quantification of this compound. In cases where analysis of multiple
 
pollutants are necessary, mass spectrometric detectors, in spite of their
 






Methods used for the analysis of N-nitrosodi-n-propylamine in
 
environmental samples are given in Table 6-2. Two pretreatment methods are
 
most suitable for the analysis of this compound in environmental samples.
 
When the matrix is not too complex, as in the case of drinking water,
 
surface water, groundwater and wastewater, solvent extraction is the
 
preferred method. With more complex matrices as soil and foodstuffs, vacuum
 
distillation and cold trapping is more suitable. The three methods
 
commonly used for the quantification of this compound in environmental
 
samples are mass spectrometry, nitrogen-phosphorus detectors (NPD) and TEA
 
in chemilumin escence mode. Each of these detectors has its own advantages
 
and disadvantages. When a high sensitivity is required, a method using a
 
TEA detector may be the method of choice. For multipollutant analysis in a
 
single sample, mass spectrometry may be more suitable. Nitrogen-phosphorus
 
detectors, on the other hand, may be more cost-effective and will provide
 
reasonable specificity and sensitivity for nitroso compounds. A Hall
 
detector in the pyrolytic mode may be preferable over NPD detectors because
 
it may require less sample clean-up (Rhoades et al. 1980).
 
6.3 ADEQUACY OF THE DATA BASE
 
Section 104 (i) (5) of CERCLA, directs the Administrator of ATSDR (in
 
consultation with the Administrator of EPA and agencies and programs of the
 
Public Health Service) to assess whether adequate information on the health
 
effects of N-nitrosodi-n-propylamine is available. Where adequate
 
information is not available, ATSDR, in cooperation with the National
 
Toxicology Program (NTP), is required to assure the initiation of a program
 
of research designed to determine these health effects (and techniques for
 
developing methods to determine such health effects). The following
 
discussion highlights the availability, or absence, of exposure and toxicity
 










relevance of identified data needs is also included. In a separate effort,
 
ATSDR, in collaboration with NTP and EPA, will prioritize data needs across
 




Methods for Determining Parent Compound and Metabolites in Biological
 
Materials. Analytical methods of suitable sensitivity and specificity are
 
available for the quantification of N-nitrosodi-n-propylamine in biological
 
samples. The study of the levels of the parent compound in human blood,
 
urine or other biological matrices can be useful in deriving a correlation
 
between the level of this compound found in the environment and those found
 
in human tissue and body fluid. Such correlation studies are not available
 
for N-nitrosodi-n-propylamine. The changes in metabolite concentrations
 
with time in human blood, urine, or other appropriate biological medium may
 
be useful in estimating its rate of metabolism in humans. In some
 
instances, a metabolite may be useful in correlating the exposed doses to
 
the human body burden. Such studies on the levels of metabolites in human
 
biological matrices are not available for this compound, although metabolic
 
products of this compound from animal and in vitro studies have been
 




Methods for Biomarkers of Exposure. No known biomarker for exposure to
 
N-nitrosodi-n-propylamine has been identified (see Subsection 2.9.2). 7­
Methyldeoxyguanosine and 06-methyldeoxyguanosine adducts are formed as a
 
result of exposure to methylated nitrosoamines. Immunological assays are
 
available for the determination of these adducts (Degan et al. 1988, Foiles
 
et al. 1988). If propyl-substituted deoxyguanosine adducts are formed from
 
N-nitrosodi-n-propylamine by similar reaction, it could be used as a
 
biomarker for N-nitrosodi-n-propylamine exposure. If such a biomarker were
 
available and a correlation were found between the level of the biomarker
 
and exposure, it could be used as a measure of exposure.
 
Methods for Determining Parent Compounds and Degradation Products in
 
Environmental Media. Analytical methods of suitable sensitivity and
 
specificity are available for the quantification of this compound in
 
environmental samples. The levels of this compound in different
 
environmental media can be used to indicate exposure of humans to this
 
compound through the inhalation of air and ingestion of drinking water and
 
foods containing N-nitrosodi-n-propylamine. If a correlation with human
 
tissue or body fluid levels were available, the intake levels from different
 
environmental sources could be used to estimate the body burden of the
 
chemical in humans. Although the products of biotic and abiotic processes
 
of this compound in the environment are adequately known, no systemic study
 
is available that measured the concentrations of its degradation products in
 
the environment. In instances where the product(s) of an environmental
 
reaction is more toxic than the parent compound, it is important that the
 






degradation products of this compound in environmental media are less toxic
 
compounds, namely n-propylamine, di-n-propylamine etc. (see Subsection
 
5.3.2). The analytical methods for the determination of the levels of these
 






No significant on-going studies are in progress for the development of
 







7. REGULATIONS AND ADVISORIES
 
International, National and State regulations and guidelines pertinent
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Acute Exposure -- Exposure to a chemical for a duration of 14 days or less,
 
as specified in the Toxicological Profiles.
 
Adsorption Coefficient (Koc) -- The ratio of the amount of a chemical
 
adsorbed per unit weight of organic carbon in the soil or sediment to the
 
concentration of the chemical in solution at equilibrium.
 
Adsorption Ratio (Kd) -- The amount of a chemical adsorbed by a sediment or
 
soil (i.e., the solid phase) divided by the amount of chemical in the
 
solution phase, which is in equilibrium with the solid phase, at a fixed
 
solid/solution ratio. It is generally expressed in micrograms of chemical
 
sorbed per gram of soil or sediment.
 
Bioconcentration Factor (BCF) -- The quotient of the concentration of a
 
chemical in aquatic organisms at a specific time or during a discrete time
 
period of exposure divided by the concentration in the surrounding water at
 
the same time or during the same time period.
 
Cancer Effect Level (CEL) -- The lowest dose of chemical in a study or
 
group of studies which produces significant increases in incidence of
 




Carcinogen -- A chemical capable of inducing cancer.
 




Chronic Exposure -- Exposure to a chemical for 365 days or more, as
 
specified in the Toxicological Profiles.
 
Developmental Toxicity -- The occurrence of adverse effects on the
 
developing organism that may result from exposure to a chemical prior to
 
conception (either parent), during prenatal development, or postnatally to
 
the time of sexual maturation. Adverse developmental effects may be detected
 
at any point in the life span of the organism.
 
Embryotoxicity and Fetotoxicity -- Any toxic effect on the conceptus as a
 
result of prenatal exposure to a chemical; the distinguishing feature
 
between the two terms is the stage of development during which the insult
 
occurred. The terms, as used here, include malformations and variations,
 
altered growth, and in utero death.
 
EPA Health Advisory -- An estimate of acceptable drinking water levels for a
 
chemical substance based on health effects information. A health advisory is
 
not a legally enforceable federal standard, but serves as technical guidance
 






Immediately Dangerous to Life or Health (IDLH) -- The maximum environmental
 
concentration of a contaminant from which one could escape within 30 min
 
without any escape-impairing symptoms or irreversible health effects.
 
Intermediate Exposure -- Exposure to a chemical for a duration of 15-364
 
days, as specified in the Toxicological Profiles,
 
Immunologic Toxicity -- The occurrence of adverse effects on the immune
 




In vitro -- Isolated from the living organism and artificially maintained,
 
as in a test tube.
 
In vivo -- Occurring within the living organism.
 
Lethal Concentration(L0) (LCLo) -- The lowest concentration of a chemical in
 
air which has been reported to have caused death in humans or animals.
 
Lethal Concentration(50) (LC50) -- A calculated concentration of a chemical
 
in air to which exposure for a specific length of time is expected to cause
 




Lethal Dose(L0) (LDLO) -- The lowest dose of a chemical introduced by a
 




Lethal Dose(50) (LD50) -- The dose of a chemical which has been calculated
 
to cause death in 50% of a defined experimental animal population.
 
Lowest-Observed-Adverse-Effect Level (LOAEL) -- The lowest dose of chemical
 
in a study or group of studies which produces statistically or biologically
 
significant increases in frequency or severity of adverse effects between
 
the exposed population and its appropriate control.
 
LT50 (lethal time) -- A calculated period of time within which a specific
 




Malformations -- Permanent structural changes that may adversely affect
 
survival, development, or function.
 
Minimal Risk Level -- An estimate of daily human exposure to a chemical
 
that is likely to be without an appreciable risk of deleterious effects
 






Mutagen -- A substance that causes mutations. A mutation is a change in the
 




Neurotoxicity -- The occurrence of adverse effects on the nervous system
 
following exposure to a chemical.
 
No-Observed-Adverse-Effect Level (NOAEL) -- That dose of chemical at which
 
there are no statistically or biologically significant increases in
 
frequency or severity of adverse.effects seen between the exposed
 
population and its appropriate control. Effects may be produced at this
 
dose, but they are not considered to be adverse.
 
Octanol-Water Partition Coefficient (Kow) -- The equilibrium ratio of the
 
concentrations of a chemical in n-octanol and water, in dilute solution.
 
Permissible Exposure Limit (PEL) -- An allowable exposure level in
 
workplace air averaged over an 8-h shift.
 
q1* - - The upper-bound estimate of the low-dose slope of the dose-response
 
curve as determined by the multistage procedure. The ql* can be used to
 
calculate an estimate of carcinogenic potency, the incremental excess cancer
 




Reference Dose (RfD) -- An estimate (with uncertainty spanning perhaps an
 
order of magnitude) of the daily exposure of the human population to a
 
potential hazard that is likely to be without risk of deleterious effects
 
during a lifetime. The RfD is operationally derived from the NOAEL (from
 
animal and human studies) by a consistent application of uncertainty factors
 
that reflect various types of data used to estimate RfDs and an additional
 
modifying factor, which is based on a professional judgment of the entire
 
database on the chemical. The RfDs are not applicable to nonthreshold
 
effects such as cancer.
 
Reportable Quantity (RQ) -- The quantity of a hazardous substance that is
 
considered reportable under CERCLA. Reportable quantities are: (1) 1 lb or
 
greater or (2) for selected substances, an amount established by regulation
 
either under CERCLA or under Sect. 311 of the Clean Water Act. Quantities
 
are measured over a 24-h period.
 
Reproductive Toxicity -- The occurrence of adverse effects on the
 
reproductive system that may result from exposure to a chemical. The
 
toxicity may be directed to the reproductive organs and/or the related
 
endocrine system. The manifestation of such toxicity may be noted as
 
alterations in sexual behavior, fertility, pregnancy outcomes, or
 








Short-Term Exposure Limit (STEL) -- The maximum concentration to which
 
workers can be exposed for up to 15 min continually. No more than four
 
excursions are allowed per day, and there must be at least 60 min between
 
exposure periods. The daily TLV-TWA may not be exceeded.
 
Target Organ Toxicity -- This term covers a broad range of adverse effects
 
on target organs or physiological systems (e.g., renal, cardiovascular)
 
extending from those arising through a single limited exposure to those
 
assumed over a lifetime of exposure to a chemical.
 
TD50 (toxic dose) -- A calculated dose of a chemical, introduced by a route
 
other than inhalation, which is expected to cause a specific toxic effect in
 
50% of a defined experimental animal population.
 
Teratogen -- A chemical that causes structural defects that affect the
 
development of an organism.
 
Threshold Limit Value (TLV) -- A concentration of a substance to which most
 
workers can be exposed without adverse effect. The TLV may be expressed as a
 
TWA, as a STEL, or as a CL.
 
Time-weighted Average (TWA) -- An allowable exposure concentration averaged
 
over a normal 8-h workday or 40-h workweek.
 
Uncertainty Factor (UF) -- A factor used in operationally deriving the RfD
 
from experimental data. UFs are intended to account for (1) the variation in
 
sensitivity among the members of the human population, (2) the uncertainty
 
in extrapolating animal data to the case of humans, (3) the uncertainty in
 
extrapolating from data obtained in a study that is of less than lifetime
 
exposure, and (4) the uncertainty in using LOAEL data rather than NOAEL
 







A peer review panel was assembled for N-nitrosodi-n-propylamine. The
 
panel consisted of the following members: Dr. Edmond LaVoie, College of
 
Pharmacy, Rutgers University; Dr. Raymond Smith, Instructor, Department of
 
Pathology and Microbiology, University of Nebraska Medical Center; Dr.
 
Frank Lu, Private Consultant, Miami, FL; and Dr. Vincent Garry, Laboratory
 
of Medicine and Pathology, University of Minnesota. These experts
 
collectively have knowledge of N-nitrosodi-n-propylamine's physical and
 
chemical properties, toxicokinetics, key health end points, mechanisms of
 
action, human and animal exposure, and quantification of risk to humans.
 
All reviewers were selected in conformity with the conditions for peer
 




A joint panel of scientists from ATSDR and EPA has reviewed the peer
 
reviewers' comments and determined which comments will be included in the
 
profile. A listing of the peer reviewers' comments not incorporated in the
 
profile, with a brief explanation of the rationale for their exclusion,
 
exists as part of the administrative record for this compound. A list of
 
databases reviewed and a list of unpublished documents cited are also
 
included in the administrative record.
 
The citation of the peer review panel should not be understood to
 
imply their approval of the profile's final content. The responsibility for
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